WHIPgroup has filed a patent infringement lawsuit on behalf of its client RegenLab USA LLC in the Southern District of New York, Case No. 17-cv-03845 (S.D.N.Y.) (filed May 22, 2017). RegenLab is a leading innovator of medical and pharmaceutical products that it distributes under the world-famous REGENLAB® brand. RegenLab developed a new and extremely effective way to enhance platelet rich plasma production that is patented in U.S. Pat. No. 8,529,957 (“the ‘957 patent”). The complaint alleges that Raj Kanodia, M.D., Garden City Dermatology, P.C., and Trifecta Health Medical P.C. infringe the ‘957 patent with their commercial promotion, use, and sale of a product called “Eclipse PRP.”
WHIPGroup previously filed a Motion to Dismiss a patent infringement suit filed against its client TomTom in the Western District of Texas. Rather than opposing WHIPGroup’s motion to dismiss, Plaintiff MDSP Technologies LLC voluntarily dismissed [Read More…]
WHIPgroup succeeded in having anticipation and indefiniteness rejections overturned by the Patent Trial and Appeal Board (PTAB). The claimed invention relates to a sequencing station that manages both sequencing and restacking tasks. The Examiner had [Read More…]
WHIPGroup filed a Motion to Dismiss for improper venue in the Western District of Texas on behalf of its client TomTom North America, Inc. Plaintiff MDSP Technologies LLC alleges that TomTom North America, Inc. infringes [Read More…]